- CRS Publications
- News
News
Authors:
Date:
Business Wire: May 26, 2016 – DUBLIN, OH, U.S.A. – Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) announced the receipt of an initial notice of award for a fast-track Small Business Innovation Research (SBIR) grant providing for up to $1.8 million from the National Institutes of Health’s (NIH’s…
Authors:
Date:
Business Wire: May 16, 2016 – STOCKHOLM, Sweden – Nanologica entered into a license and collaboration agreement with Alcyone Lifesciences to develop Abela, a treatment for motor neuron disorders including ALS.
Nanologica today announced that it has entered into a License and Collaboration…
Authors:
Date:
Business Wire: May 12, 2016 – PARIS, France, and STANS, Switzerland – NLS Pharma Group announced the submission of an Investigational New Drug Application (IND) with the U.S. Food and Drug Administration (FDA) to initiate a phase IIb clinical trial with its lead compound Mazindol. The study is…
Authors:
Date:
Business Wire: August 15, 2016 – LOUGHBOROUGH, England – Nemaura Pharma has been awarded the prestigious 2016 Frost & Sullivan award for best practices in enabling technology leadership in the transdermal drug delivery industry.
The analysts stated that “Nemaura Pharma’s drug delivery…
Authors:
Date:
This first wave of computational modeling in pharmaceutical science was the application of informatics-based methods to finding optimum drug molecule structures: drug design. We can now move beyond this, both from drug design to the design of drug delivery vehicles, nanomedicine, and from raw…
Authors:
Overview
“One Health” refers to the interconnection of health of humans, animals, and the environment. Scientists, doctors, and veterinarians working together can improve health for everyone. One example is controlling and treating cancer. Cancer is the number two cause of death in humans in the…
